
一项研究发现,随着Wegovy等减重药物在英国的使用日益增加,由于药物抑制了食欲,打击了薯片等商品的需求,年度食品杂货支出减少了10亿英镑以上(约合13亿美元)。
Published: 2026-11-19T08:01:00+08:00 Growing use of weight-loss drugs such as Wegovy in the UK has reduced annual grocery spending by more than £1 billion ($1.3 billion), a study found, as medicines reduce cravings and hit demand for things like potato chips.
消费者研究公司Worldpanel by Numerator周四发布的数据显示,至少有一名GLP-1类药物使用者的家庭,在首次开始服药后的一年里,购买的食品数量减少了4.15亿件。该公司6月份上次发布追踪报告时,这一数字约为3亿件。
Households with at least one user of GLP-1 drugs bought 415 million fewer food items in the year after they first started taking the medicine, according to data from Worldpanel by Numerator on Thursday. That compares with about 300 million when the consumer research firm last published its tracker in June.
Worldpanel估计,到2027年,英国将有超过十分之一的家庭拥有GLP-1类药物使用者。目前这一比例已达8.5%,大致相当于素食者和鱼素者家庭比例之和。
Worldpanel estimates more than one in ten UK households will have a GLP-1 user by 2027. The proportion is already 8.5%, roughly the same level as those containing vegetarians and pescatarians combined.
Worldpanel公共部门与营养主管Chantel Kennaugh表示:“这不是昙花一现的趋势,而是一场剧变,要求零售商和制造商重新思考他们的策略。”
“This is not a flash-in-the-pan trend, but a seismic change that requires retailers and manufacturers to rethink their strategies,” said Chantel Kennaugh, head of public sector and nutrition at Worldpanel.
企业和零售商已在针对食欲变小和消费转移做出调整。Morrisons和Tesco Plc等超市已推出面向GLP-1类药物使用者的小份量、高蛋白餐食。健康与药房连锁Boots推出了专注于消化健康的产品。
Businesses and retailers are already adapting to smaller appetites and shifting spending. Morrisons and Tesco Plc are among the supermarkets that have launched smaller, protein-rich meals aimed at GLP-1 users. Health and pharmacy chain Boots has introduced products focused on digestive health.
根据该研究,部分被挤占的食品杂货资金正流向服装鞋类等其他领域。GLP-1类药物使用者在健康美容产品上的支出比Worldpanel预期多出7800万英镑。
Some of the displaced grocery money is moving to other areas such as clothing and footwear. GLP-1 users spent £78 million more than Worldpanel expected on health and beauty products, according to the study.